The EU has approved lenacapavir, a twice-yearly HIV prevention shot that could replace daily pills, but experts say access ...

Resistance to ART was associated with poor clinical outcomes and increased economic burden in a national sample of veterans with HIV infection in the United States.

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...